Fresenius Medical Care AG & Co. KGaA Market Share Analysis

Summary

GlobalData’s new report, “Fresenius Medical Care AG & Co. KGaA Market Share Analysis” provides in-depth information on Fresenius Medical Care AG & Co. KGaA’s market position in the different medical equipment markets it operates in. The report provides Fresenius Medical Care AG & Co. KGaA market share information in one key market category – Renal Dialysis Equipment. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Fresenius Medical Care AG & Co. KGaA operates in – Nephrology and Urology Devices.

- Fresenius Medical Care AG & Co. KGaA’s company shares (in Revenues) information for all the key countries the company has presence in – China, Australia, India, Japan, Germany, France, Spain, United Kingdom, Italy, Canada, United States and Brazil.

- Fresenius Medical Care AG & Co. KGaA’s company shares (in Revenues) information for all the key market category the company has presence in – Renal Dialysis Equipment.

- All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia-Pacific, South and Central America and Middle East and Africa.

- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.

- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.

- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Fresenius Medical Care AG & Co. KGaA operates in.

- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.

- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.

- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.

- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Fresenius Medical Care AG & Co. KGaA’s market positions.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 What Is This Report About? 9

3 Definitions of Markets/Categories Covered 10

3.1 Nephrology and Urology Devices 10

3.1.1 Renal Dialysis Equipment 10

4 Company Snapshot 11

4.1 Key Facts 11

4.2 Company Overview 11

4.3 Financial Performance 11

4.4 SWOT Snapshot 11

5 Business Description 12

5.1 Business Overview 12

5.2 Dialysis Products 12

5.2.1 Overview 12

5.2.2 Financials 12

5.3 Dialysis Services 13

5.3.1 Overview 13

5.3.2 Financials 13

5.3.3 Market View 13

5.4 Major Products and Services 13

5.4.1 Overview 13

6 History 15

7 SWOT Analysis 18

7.1 Overview 18

7.2 Fresenius Medical Care AG & Co. KGaA Strengths 18

7.2.1 Strong Cash Reserves 18

7.2.2 Vertically Integrated Operations 19

7.2.3 Financial Performance 19

7.2.4 Worldwide Manufacturing Facilities 19

7.2.5 Leading Market Position 20

7.3 Fresenius Medical Care AG & Co. KGaA Weaknesses 20

7.3.1 Reliance on Referrals 20

7.3.2 Product Recalls 20

7.3.3 Revenue Concentration 20

7.4 Fresenius Medical Care AG & Co. KGaA Opportunities 21

7.4.1 Expanding Peritoneal Dialysis Market 21

7.4.2 Regulatory Support 21

7.4.3 Expansion in High Growth Markets 21

7.4.4 Growing Incidence of End-Stage Renal Disease 21

7.4.5 Partnership and Agreements 22

7.4.6 Inorganic Growth: Strategic Acquisitions 22

7.5 Fresenius Medical Care AG & Co. KGaA Threats 23

7.5.1 Rapid Technological Change 23

7.5.2 Risk of Infection 23

7.5.3 Cost Containment Pressures 23

7.5.4 Stringent Regulations 23

7.5.5 Intense Competition 23

8 Competitors 24

9 Competitive Landscape 25

9.1 Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 25

9.2 Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Region, Market Share (2011) 27

9.3 Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Country, Market Share (2011) 29

10 Key Employees 31

11 Key Employee Biographies 32

12 Company Statement 33

13 Locations And Subsidiaries 35

13.1 Head Office 35

13.2 Other Locations & Subsidiaries 35

14 Financial Deals Landscape 37

14.1 Fresenius Medical Care AG & Co. KGaA, Deals Volume Summary, 2006 to YTD 2012 37

15 Fresenius Medical Care AG & Co. KGaA Detailed Deal Summary 39

15.1 Asset Purchase 39

15.1.1 Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 39

15.1.2 Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 41

15.1.3 Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro 42

15.1.4 Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical 44

15.1.5 Fresenius Medical Care Acquires Dialysis Stations From Hand Prod 45

15.1.6 Fresenius Medical Care Acquires 11 Dialysis Clinics 46

15.2 Partnerships 47

15.2.1 Interface Biologics Enters Into Licensing Agreement With Fresenius Medical Care 47

15.2.2 Fresenius Medical Care Enters Into An Agreement With NIKKISO 48

15.2.3 BTG International Enters Into A Licensing Agreement With Fresenius Medical Care 49

15.2.4 Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For $800 Million 50

15.2.5 Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For $316.4 Million 51

15.2.6 Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For $700 Million 52

15.2.7 Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For $133.7 Million 53

15.2.8 Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $550 Million 54

15.2.9 Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $400 Million 55

15.2.10 Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For $650 Million 56

15.2.11 Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For $403 Million 57

15.2.12 Fresenius Medical Care Completes Private Placement Of Senior Notes For $360.42 Million 59

15.2.13 Fresenius Medical Care Completes Private Placement Of $500 Million 60

15.3 Acquisition 61

15.3.1 Fresenius Medical Care Acquires HIT Services Group 61

15.3.2 Fresenius Medical Acquires Renal Solutions 62

16 Recent Developments 63

16.1 Strategy And Business Planning 63

16.1.1 Dec 22, 2011: Fresenius Medical Care Enters Dialysis Services Market In Ecuador 63

16.1.2 Nov 03, 2011: Fresenius Medical Selects ViryaNet’s G4 Workforce Management Solution 63

16.1.3 Jul 23, 2010: Fresenius Medical Care Enters Into Long-Term Distribution Agreement In Japan And Expands Dialysis Products Business In Korea 64

16.1.4 Mar 06, 2008: Fresenius Expands Dialyzer Production Capacity In Germany 64

16.2 Financial Announcements 65

16.2.1 Feb 21, 2012: Fresenius Medical Reports Revenue Of $12.8 Billion In 2011 65

16.2.2 Nov 02, 2011: Fresenius Medical Reports Revenues Of $3.2 Billion In Q3 2011 67

16.2.3 Aug 02, 2011: Fresenius Medical Reports Total Net Revenue Of $3.2 Billion In Q2 2011 69

16.2.4 May 04, 2011: Fresenius Medical Reports Net Revenue Of $3 Billion In Q1 2011 70

16.2.5 Feb 23, 2011: Fresenius Medical Reports Total Net Revenues Of $12 Billion In 2010 71

16.2.6 Nov 02, 2010: Fresenius Medical Reports Total Net Revenue Of $3.1 Billion In Q3 2010 72

16.2.7 Aug 03, 2010: Fresenius Medical Reports Total Net Revenues Of $2.9 Billion In Q2 2010 74

16.2.8 May 04, 2010: Fresenius Medical Reports Net Revenues Of $2.9 Billion In Q1 2010 75

16.2.9 Feb 24, 2010: Fresenius Medical Reports Net Income Of $891 Million In 2009 78

16.2.10 Nov 03, 2009: Fresenius Medical Reports Net Income Of $244.5 million In Q3 2009 80

16.2.11 Aug 04, 2009: Fresenius Medical Reports Net Income Of $239.03 Million In Q2 2009 82

16.2.12 Apr 30, 2009: Fresenius Medical Posts Net Income Of $198 Million In Q1 2009 84

16.2.13 Feb 19, 2009: Fresenius Medical Reports 2008 Results 86

16.2.14 Nov 04, 2008: Fresenius Medical Reports 3Q 2008 Results 88

16.2.15 Jul 17, 2008: Fresenius Medical Reports Preliminary 2Q 2008 Results 90

16.2.16 May 20, 2008: Fresenius Medical Provides Revenue Guidance For Remainder Of 2008 90

16.2.17 Apr 30, 2008: Fresenius Medical Declares Q1 2008 Results 91

16.2.18 Feb 20, 2008: Fresenius Medical Declares Q4 2007 Results 91

16.2.19 Oct 31, 2007: Fresenius Medical Declares Q3 2007 Results 93

16.2.20 Aug 02, 2007: Fresenius Medical Declares Q2 2007 Results 93

16.2.21 May 15, 2007: Fresenius Medical Announces Share Split Approval 94

16.2.22 May 02, 2007: Fresenius Medical Declares Q1 2007 Results 95

16.2.23 Feb 22, 2007: Fresenius Medical Declares Q4 2006 Results 95

16.2.24 Oct 31, 2006: Fresenius Medical Declares Q3 2006 Results 96

16.3 Research And Development 97

16.3.1 May 05, 2009: Fresenius Opens Dialysis Clinic In Sweden 97

16.4 Corporate Communications 97

16.4.1 Dec 09, 2009: Fresenius Medical Care Announces Management Board Changes 97

16.4.2 Mar 10, 2009: Fresenius Medical CFO Resigns 99

16.5 Legal and Regulatory 100

16.5.1 Sep 17, 2009: Appeals Court Remands Patent Case Between Baxter And Fresenius 100

16.5.2 May 06, 2009: Fresenius Medical Announces Completion Of Government Investigation 100

16.6 Government and Public Interest 100

16.6.1 Feb 10, 2012: Aetna And Fresenius Medical Care Begin Chronic Kidney Disease Management Program 100

16.6.2 Mar 17, 2011: Fresenius Medical Care Patient Safety Organization Secures US Certification 101

16.6.3 Mar 17, 2011: Fresenius Medical Care’s Patient Safety Organization Receives Official Certification From US Department of Health & Human Services 102

16.7 Product News 103

16.7.1 Nov 18, 2010: Fresenius Introduces 2008T Hemodialysis Delivery System At Renal Week 2010 103

16.8 Other Significant Developments 103

16.8.1 Jan 19, 2011: Fresenius Medical Care Wins Contract For Comprehensive Dialysis Care And Performance-Oriented Reimbursement In Spain 103

17 Appendix 104

17.1 Research Methodology 105

17.2 Secondary Research 105

17.3 Primary Research 105

17.4 Models 106

17.5 Forecasts 106

17.6 Expert Panels 106

17.7 GlobalData Consulting 106

17.8 Currency Conversion 107

17.9 Contact Us 108

17.10 Disclaimer 108

1.1 List of Tables

Table 1: Fresenius Medical Care AG & Co. KGaA, Key Facts, 2011 11

Table 2: Fresenius Medical Care AG & Co. KGaA, SWOT Analysis, 2011 18

Table 3: Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Company Share by Revenue ($m), 2011 26

Table 4: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Region, Revenue ($m) and Market Share (%), 2011 28

Table 5: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices, (Renal Dialysis Equipment) by Country, Revenue ($m) and Market Share (%), 2011 30

Table 6: Fresenius Medical Care AG & Co. KGaA, Key Employees 31

Table 7: Fresenius Medical Care AG & Co. KGaA, Other Locations 35

Table 8: Fresenius Medical Care AG & Co. KGaA, Subsidiaries 36

Table 9: Fresenius Medical Care AG & Co. KGaA, Deals Volume Summary, 2006 to YTD 2012 37

Table 10: Fresenius Medical Care AG & Co. KGaA, Deals Summary, 2006 to YTD 2012 38

Table 11: Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 39

Table 12: Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 41

Table 13: Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro 42

Table 14: Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical 44

Table 15: Fresenius Medical Care Acquires Dialysis Stations From Hand Prod 45

Table 16: Fresenius Medical Care Acquires 11 Dialysis Clinics 46

Table 17: Interface Biologics Enters Into Licensing Agreement With Fresenius Medical Care 47

Table 18: Fresenius Medical Care Enters Into An Agreement With NIKKISO 48

Table 19: BTG International Enters Into A Licensing Agreement With Fresenius Medical Care 49

Table 20: Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For $800 Million 50

Table 21: Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For $316.4 Million 51

Table 22: Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For $700 Million 52

Table 23: Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For $133.7 Million 53

Table 24: Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $550 Million 54

Table 25: Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For $400 Million 55

Table 26: Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For $650 Million 56

Table 27: Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For $403 Million 57

Table 28: Fresenius Medical Care Completes Private Placement Of Senior Notes For $360.42 Million 59

Table 29: Fresenius Medical Care Completes Private Placement Of $500 Million 60

Table 30: Fresenius Medical Care Acquires HIT Services Group 61

Table 31: Fresenius Medical Acquires Renal Solutions 62

Table 32: USD to Local Currency, Average Exchange Rate, 2011 107

1.2 List of Figures

Figure 1: Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 25

Figure 2: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Region, Market Share (%), 2011 27

Figure 3: Fresenius Medical Care AG & Co. KGaA, Nephrology and Urology Devices (Renal Dialysis Equipment), by Country, Market Share (%), 2011 29

Figure 4: Fresenius Medical Care AG & Co. KGaA, Deals Volume Summary, 2006 to YTD 2012 37